← FDA Drug Approvals (Drugs@FDA)

RYZUMVI

NDA · New Drug Application · Sponsor: FAMYGEN LIFE SCI · Approved 2023-09-25

Drug application

FDA Application #

NDA217064

Application type

New Drug Application

Brand name

RYZUMVI

Generic name

PHENTOLAMINE MESYLATE

Active ingredients

PHENTOLAMINE MESYLATE

Dosage form

SOLUTION

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

FAMYGEN LIFE SCI

Manufacturer

Oyster Point Pharma, Inc.

First approval

2023-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown